Bendectin and Birth Defects : : The Challenges of Mass Toxic Substances Litigation / / Michael D. Green.
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabi...
Saved in:
| Superior document: | Title is part of eBook package: De Gruyter University of Pennsylvania Press Package Archive 1898-1999 |
|---|---|
| VerfasserIn: | |
| Place / Publishing House: | Philadelphia : : University of Pennsylvania Press, , [2016] ©1996 |
| Year of Publication: | 2016 |
| Language: | English |
| Online Access: | |
| Physical Description: | 1 online resource (384 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!